CRNX - Crinetics Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.83
DETAILS
HIGH:
$105.00
LOW:
$67.00
MEDIAN:
$85.50
CONSENSUS:
$85.83
UPSIDE:
133.23%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 0 | $0 | -- | -2,337,034 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-08 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 19,336 | $19.64 | $380K |
| 2026-04-08 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 9,624 | $20.02 | $193K |
| 2026-04-08 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | SELL | 85,163 | $40.10 | $3.4M |
| 2026-04-08 | Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 49,474 | $23.98 | $1.2M |
| 2026-03-16 | Knight Jeff E. | officer: Chief Operating Officer | SELL | 5,950 | $37.11 | $221K |
| 2026-03-16 | Betz Stephen F. | officer: Chief Scientific Officer | SELL | 6,371 | $37.11 | $236K |
| 2026-03-16 | Betz Stephen F. | officer: Chief Scientific Officer | SELL | 4,241 | $37.77 | $160K |
| 2026-03-16 | Struthers Richard Scott | director, officer: President & CEO | SELL | 13,196 | $37.11 | $490K |
| 2026-03-16 | Struthers Richard Scott | director, officer: President & CEO | SELL | 8,785 | $37.77 | $332K |
| 2026-03-16 | Knight Jeff E. | officer: Chief Operating Officer | SELL | 3,961 | $37.77 | $150K |
| 2026-03-12 | Vivaldi Coelho Rogerio | director | SELL | 4,477 | $36.08 | $162K |
| 2026-03-12 | Vivaldi Coelho Rogerio | director | SELL | 523 | $36.77 | $19K |
| 2026-03-03 | Schilke Tobin | officer: Chief Financial Officer | SELL | 6,713 | $39.67 | $266K |
| 2026-03-03 | Okey Stephanie | director | SELL | 3,000 | $39.67 | $119K |
| 2026-02-23 | Struthers Richard Scott | director, officer: President & CEO | A-Award | 62,000 | -- | -- |
| 2026-02-23 | Struthers Richard Scott | director, officer: President & CEO | A-Award | 228,000 | $43.79 | $10.0M |
| 2026-02-23 | Schilke Tobin | officer: Chief Financial Officer | A-Award | 32,000 | -- | -- |
| 2026-02-23 | Knight Jeff E. | officer: Chief Operating Officer | A-Award | 55,000 | $43.79 | $2.4M |
| 2026-02-23 | Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 30,000 | -- | -- |
| 2026-02-23 | Schilke Tobin | officer: Chief Financial Officer | A-Award | 50,000 | $43.79 | $2.2M |
| 2026-02-23 | Knight Jeff E. | officer: Chief Operating Officer | A-Award | 34,000 | -- | -- |
| 2026-02-23 | Kalofonos Isabel | officer: Chief Commercial Officer | A-Award | 34,000 | -- | -- |
| 2026-02-23 | Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 47,000 | $43.79 | $2.1M |
| 2026-02-23 | Kalofonos Isabel | officer: Chief Commercial Officer | A-Award | 55,000 | $43.79 | $2.4M |
| 2026-01-05 | Kalofonos Isabel | officer: Chief Commercial Officer | SELL | 2,500 | $55.00 | $138K |